Amneal Pharmaceuticals, Inc.
(NYSE : AMRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.20%157.980.7%$1165.17m
PFEPfizer Inc. 0.28%34.490.9%$1067.32m
MRKMerck & Co., Inc. 2.10%74.670.7%$877.51m
BMYBristol-Myers Squibb Co. 0.72%60.871.0%$840.70m
ABBVAbbVie, Inc. 0.25%106.971.9%$718.22m
LLYEli Lilly & Co. 0.33%207.611.1%$637.99m
AZNAstraZeneca Plc 0.27%48.191.2%$487.64m
GSKGlaxoSmithKline Plc 0.63%35.130.2%$274.14m
NVSNovartis AG -0.13%83.900.2%$166.11m
SNYSanofi 0.24%46.700.2%$163.54m
VTRSViatris, Inc. -0.50%13.840.0%$133.84m
VERUVeru, Inc. 1.26%12.490.0%$122.62m
KALVKalVista Pharmaceuticals, Inc. -1.54%30.410.4%$98.10m
NVONovo Nordisk A/S -0.70%69.120.1%$90.72m
RPRXRoyalty Pharma Plc 5.95%45.070.2%$84.42m

Company Profile

Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.